Rhaeos is a clinical stage medical device company.
Rhaeos, the world's first wearable shunt monitor, aims to improve the quality care for patients with hydrocephalus through a novel, thermal biosensor. Developed within Northwestern University with collaboration between Dr. John Rogers, McCormick School of Engineering, Feinberg School of Medicine and Kellogg School of Management, Rhaeos represents a unique multidisciplinary translational effort for an important clinical need.
Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
---|---|---|---|---|---|---|
Feb 18, 2021 | Grant | $1.19M | 1 | National Science Foundation | — | Detail |
Nov 25, 2019 | Grant | $250K | 1 | National Science Foundation | — | Detail |
Investor Name | Lead Investor | Funding Round |
---|---|---|
National Science Foundation | Yes | Grant |